Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
| Filename | 478. Maurer et al., Sustained safety CSU, OA, Allergy 2022.pdf |
| Filesize | 918.98 KB |
| Version | o.478 |
| Date added | April 25, 2023 |
| Downloaded | 0 times |
| Category | Original Work |
| Authors | Maurer, M., Giménez-Arnau, A., Bernstein, J. A., Chu, C. Y., Danilycheva, I., Hide, M., Makris, M., Metz, M., Savic, S., Sitz, K., Soong, W., Staubach, P., Sussman, G., Barve, A., Burciu, A., Hua, E., Janocha, R., and Severin, T. |
| Citation | Maurer, M., Giménez-Arnau, A., Bernstein, J. A., Chu, C. Y., Danilycheva, I., Hide, M., Makris, M., Metz, M., Savic, S., Sitz, K., Soong, W., Staubach, P., Sussman, G., Barve, A., Burciu, A., Hua, E., Janocha, R., and Severin, T.: Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study. Allergy 2022: 77; 2175-2184. |
| Corresponding authors | Maurer, M. |
| DocNum | o.478 |
| DocType | |
| IF | 12.40 |
| Publisher | Allergy |
| ReleaseDate | 2022 |
(Last update: 12.2023)
| Number of original publications in peer-reviewed journals: | 580 |
| Number of reviews in peer-reviewed journals: | 210 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
| Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
| Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
| Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.